Clinical trial
A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older
NCT07489183 is registered in ClinicalTrials.gov with Dong Wha Pharmaceutical Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older
- Lead sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 23, 2021
- Completion date
- September 7, 2023
- Enrollment
- 641 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.